Erin Paul, MD Email Erin Paul
-
- Positions
- ASSISTANT PROFESSOR | Pediatrics, Cardiology
- ASSISTANT PROFESSOR | Diagnostic, Molecular and Interventional Radiology
-
- Specialties
- Pediatrics
- Pediatric Cardiology
-
- Language
- English
-
- Hospital Affiliations
- Mount Sinai Morningside and Mount Sinai West
- The Mount Sinai Hospital
- Mount Sinai Beth Israel
- Mount Sinai Queens
-
- Phone
- Mount Sinai Kravis Children's Heart Center 844-733-7692 844-733-7692
- 844-733-7692 844-733-7692
- Refuah Health 845-354-9300 845-354-9300
Erin Paul, MD, is an attending physician in the Division of Pediatric Cardiology in the Jack and Lucy Clark Department of Pediatrics at the Icahn School of Medicine at Mount Sinai and Mount Sinai Kravis Children's Heart Center at Mount Sinai Kravis Children's Hospital.
Dr. Paul received her Bachelor of Arts in Neurobiology at Harvard College. She then attended Columbia University College of Physicians and Surgeons where she received her Medical Degree. Dr. Paul completed a residency in pediatrics and fellowship in pediatric cardiology at New York-Presbyterian Morgan Stanley Children’s Hospital. At New York-Presbyterian Morgan Stanley Children’s Hospital, Dr. Paul was Chief Fellow, and stayed on to complete an additional year of advanced non-invasive imaging training. Before coming to Mount Sinai, Dr. Paul was an Attending Physician in Pediatrics at Children’s Hospital at Montefiore.
Dr. Paul’s research focuses on the areas of fetal cardiology, cardiac imaging, neurodevelopmental outcomes for children with congenital heart disease, and general cardiology. She has given numerous national lectures, and has had her work published in many abstracts, case reports, and manuscripts. Dr. Paul’s areas of clinical focus include fetal cardiology, echocardiography, neurodevelopmental outcomes in congenital heart disease, and fetal counseling, among others.
Education
MD, Columbia University College of Physicians and Surgeons
Language
English
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Paul did not report having any of the following types of financial relationships with industry during 2020 and/or 2021: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website.
Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.